Empagliflozin for heart failure with preserved ejection fraction: targeting cardiac endothelial cell-cardiomyocyte interaction

Autor: Juni, R., Kuster, D.W.D., Goebel, M., Helmes, M., van der Velden, J., Musters, R., Koolwijk, P., Paulus, W., van Hinsbergh, V.
Zdroj: In Journal of Molecular and Cellular Cardiology July 2018 120 Supplement:27-28
Databáze: ScienceDirect